Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M58.9Revenue $M0.2Net Margin (%)-9,306.0Z-Score-3.9
Enterprise Value $M35.8EPS $-0.1Operating Margin %-9,819.6F-Score5
P/E(ttm))0Cash Flow Per Share $-0.1Pre-tax Margin (%)-9,306.0Higher ROA y-yY
Price/Book1.910-y EBITDA Growth Rate %0Quick Ratio4.9Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-1.1Current Ratio4.9Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-51.0Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-58.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M184ROI % (ttm)-49.0Gross Margin Increase y-yY

Gurus Latest Trades with HEB

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

HEB is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


HEB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
STRAYER DAVID RMedical Director 2012-05-18Buy50,000$0.2619.23 view
Lander Russel JVP of Process/QualityAssurance 2011-03-01Buy50,000$0.46-32.61 view
Lander Russel JVP of Process/QualityAssurance 2010-08-23Buy4,910$0.51-39.22 view
CARTER WILLIAM ACEO, 10% Owner 2010-08-10Sell377,388$0.49-36.73 view
STRAYER DAVID RMedical Director 2010-06-23Sell50,900$0.55-43.64 view
STRAYER DAVID RMedical Director 2010-06-16Buy230,586$0.57-45.61 view
Bernhardt Charles Thomas IIICFO 2010-06-15Sell87,794$0.59-47.46 view
Springate Wayne S.Vice President of Operations 2010-06-15Sell83,104$0.59-47.46 view
CARTER WILLIAM ACEO, 10% Owner 2010-06-11Buy500,000$0.66-53.03 view
Springate Wayne S.Vice President of Operations 2009-12-15Buy877$0.56-44.64 view

Press Releases about HEB :

    Quarterly/Annual Reports about HEB:

    News about HEB:

    Articles On GuruFocus.com
    Hemispherx Biopharma Inc Reports Operating Results (10-Q/A) Feb 14 2011 
    Hemispherx Biopharma Inc Reports Operating Results (10-K/A) Feb 14 2011 
    Hemispherx Biopharma Inc Reports Operating Results (10-Q/A) Feb 14 2011 
    Hemispherx Biopharma Inc Reports Operating Results (10-Q/A) Feb 14 2011 
    Hemispherx Biopharma Inc Reports Operating Results (10-Q) Nov 08 2010 
    Weekly CEO Sells Highlight: Hemispherx Biopharma Inc, ADESA Inc, Entergy Corp, and Danaher Corp. Aug 15 2010 
    Hemispherx Biopharma Inc Reports Operating Results (10-Q) Aug 06 2010 
    Hemispherx Biopharma Inc (HEB) CEO William A Carter buys 500,000 Shares Jul 01 2010 
    Weekly CFO Buys Highlight: Wireless Telecom Group, ValueVision Media, American River Bankshares, Hem Dec 12 2009 
    Hemispherx Biopharma Inc (HEB) CFO Charles Thomas Iii Bernhardt buys 2,000 Shares Dec 08 2009 

    More From Other Websites
    8:39 am Hemispherx Biopharma's drug Ampligen Plus Intranasal seasonal influenza vaccine induces... Sep 15 2014
    Hemispherx' Drug Ampligen Plus Intranasal Seasonal Influenza Vaccine Induces Cross-Reactive Antibody... Sep 15 2014
    Hemispherx Biopharma and the Swiss Department of Defense, Civil Protection and Sports Expand Their... Sep 10 2014
    Hemispherx Biopharma and United States Army Medical Research Institute of Infectious Diseases... Sep 08 2014
    Hemispherx Biopharma to Present at the 16th Annual Rodman & Renshaw Global Investment Conference in... Sep 03 2014
    HEMISPHERX BIOPHARMA INC Financials Aug 19 2014
    Hemispherx Biopharma Announces Financial Results for the Six Months Ended June 30, 2014 Aug 11 2014
    HEMISPHERX BIOPHARMA INC Files SEC form 10-Q, Quarterly Report Aug 08 2014
    Hemispherx's Two Drugs, Ampligen(R) and Alferon(R) Ranked Highly in Sensitivity Testing Against... Aug 04 2014
    Shareholder Suit Involving Loser-Pays Provision Heats Up in Delaware Jul 22 2014
    Hemispherx achieves high ranking in sensitivity testing against MERS/SARS Jul 22 2014
    Hemispherx Achieves High Ranking in Sensitivity Testing Against MERS/SARS Coronaviruses Compared to... Jul 22 2014
    Hemispherx Biopharma and Bioclones, a Leading South African Biotechnology Company, Join Forces on... Jul 14 2014
    HEMISPHERX BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments... Jul 10 2014
    Hemispherx, Bioclones to collaborate on HIV/AIDS eradication Jul 08 2014
    Hemispherx Biopharma and Bioclones Join Forces in Effort to Eradicate HIV/AIDS Virus Based on Recent... Jul 08 2014
    Hemispherx Biopharma to Present During the 2014 BIO International Convention June 26 Jun 25 2014
    Hemispherx Announces New Publication With Potential Insight Into High Mortality Rate in Middle... Jun 16 2014
    Hemispherx confirms Alferon N inhibits replication of MERS virus in vitro Jun 03 2014
    Hemispherx receives new U.S. composition of matter patent covering Ampligen May 27 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK